Taiwanese Pharmaceuticals & Biotech Low Leverage High Rewards

PharmaEngine

Market Cap: NT$10.1b

A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.

Syngen BiotechLtd

Market Cap: NT$3.2b

Engages in the research, development, manufacturing, and sale of microbial pharmaceutical raw materials, biological pesticides, fertilizers and biochemical nutritional products, and preventive medicines in Taiwan, China, and internationally.

Standard Chemical & Pharmaceutical

Market Cap: NT$10.6b

Manufactures and sells pharmaceutical products in Taiwan and internationally.

Chi Sheng Pharma & Biotech

Market Cap: NT$1.7b

Manufactures, processes, imports, exports, and sells western medicines, cosmetics, health food products, medical devices, and animal medicines in Taiwan and internationally.

TTY Biopharm

Market Cap: NT$20.2b

Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan, the United States, and internationally.

TSH Biopharm

Market Cap: NT$2.2b

Develops and markets pharmaceutical products in Taiwan and Asia.

Sunmax Biotechnology

Market Cap: NT$21.6b

A biomedical company, develops, manufactures, and markets biomedical grade collagen and skin care product in Taiwan and Mainland China.

Sinphar PharmaceuticalLtd

Market Cap: NT$5.7b

Engages in the production, processing, selling, and trading of various medicines, chinese medicines, medical cosmetic products and nutrients in Taiwan, Mainland China, Vietnam, Indonesia, and internationally.

SYN-TECH Chem. & Pharm

Market Cap: NT$3.3b

Manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally.